(Washington University School of Medicine) A newly identified cancer biomarker could define a new subtype of breast cancer as well as offer a potential way to treat it, say researchers at Washington University School of Medicine in St. Louis.
Further information:
Related posts:
- MRI finds tumors in second breast of women diagnosed with cancer in one breast, Mayo researchers say
- Role of traditional and new biomarkers in breast carcinogenesis
- Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18
- PINC trial launched to test new treatment for pre-invasive breast cancer
- MRI Finds Tumors in Second Breast of Women Diagnosed with Cancer in One Breast, Mayo Clinic Researchers Say

Posted in